pharmaphorum

SEPTEMBER 27, 2022

Ben Hargreaves finds that the next step to enhance these treatments further could be to find synergies with emerging therapies employing similar modes of action, such as therapeutic cancer vaccines. One area that is becoming more widely discussed with the potential to be added to this group is that of therapeutic cancer vaccines.

Vaccines 97

Vaccines Immunization 97

European Pharmaceutical Review

NOVEMBER 10, 2023

The US Food and Drug Administration (FDA) has approved Valneva SE’s IXCHIQ ® , the first chikungunya vaccine to be authorised in the world. The single-dose, live-attenuated vaccine is indicated for preventing chikungunya virus disease in individuals over 18 years old who are at increased risk of contracting the virus.

Vaccines 52

Vaccines Adverse Reactions FDA Immunization 52

Pharmaceutical Technology

OCTOBER 28, 2022

On 24 October, American vaccine developer Vaxcyte shared positive topline data from a Phase I/II study of its multivalent conjugate pneumococcal vaccine VAX-24 , bringing the 24-valent pneumococcal jab one step closer to market. What’s more, VAX-24 achieved a higher immune response to 16 of the 20 serotypes it shares with Prevnar 20.

Vaccines 64

Vaccines FDA Immunization 64

Hospital Pharmacy Europe

OCTOBER 14, 2024

The idea of cancer vaccines is not new, but Dr Victoria Kunene, consultant medical oncologist at Queen Elizabeth Hospital Birmingham, UK, is leading the charge in their latest iteration: personalised preventative and therapeutic mRNA vaccines against colorectal cancer.

Vaccines 52

Vaccines Chemotherapy Hospitals Immunization 52

PharmaShots

FEBRUARY 20, 2023

Shots: The USPTO issued the company a patent for its transformative technology to produce orally delivered animal vaccines by the number Patent US-11566255-B2, "Expression of PEDV Sequences in Plants and Plant Produced Vaccine for Same" on the 31st of Jan 2023 The patent covers foundational technology for the company’s first vaccine (..)

Vaccines 40

Vaccines Immunization FDA 40

Pharmaceutical Technology

APRIL 24, 2023

Since then, the field of nanomedicine has steadily progressed to reach high points such as the successful use of nanotechnology to deliver messenger RNA (mRNA)-based Covid-19 vaccines. In the case of most mRNA vaccines, a lipid nanoparticle-based approach was chosen due to its ability to protect the mRNA in the body and prevent degradation.

Vaccines 59

Vaccines Immunization Medical Schools FDA 59

European Pharmaceutical Review

DECEMBER 18, 2023

billion ($260 million) to establish a state-of-the-art research and vaccine development initiative in Denmark. Research at the Novo Nordisk Foundation Initiative for Vaccines and Immunity, or NIVI, will focus initially on creating new or improved vaccines for tuberculosis, influenza , and Group A Streptococcus (GAS).

Vaccines 105

Vaccines Immunization 105

European Pharmaceutical Review

SEPTEMBER 12, 2023

A T-cell epitope cancer vaccine significantly improved overall survival in non-small cell lung cancer (NSCLC) compared to chemotherapy, Phase III data published in Annals of Oncology has shown. The cancer vaccine offered an overall survival of 11.1 The overall survival rate at one year with Tedopi was 44.4 percent versus 27.5

Vaccines 98

Vaccines Chemotherapy Immunization 98

Digital Pharmacist

SEPTEMBER 20, 2023

The Medicare Open Enrollment period for 2024 is quickly approaching – this is a critical time for both your patients and your pharmacy. Below is a breakdown of what you need to be aware of when assisting patients with 2024 open enrollments, as well as a few tips on how your pharmacy can prepare for this busy time at the pharmacy.

Independent Pharmacies 105

Independent Pharmacies Insurance Nursing Homes Immunization 105

European Pharmaceutical Review

JUNE 13, 2024

In April 2024, Ocugen received US Food and Drug Administration (FDA) clearance to initiate the Phase III liMeliGhT clinical trial for OCU400 for retinitis pigmentosa. In May 2024, Ocugen announced the second cohort (medium dose) completed dosing in the dose-escalation phase. Tell us about Ocugen’s lead programme, OCU400.

Immunization 145

Immunization FDA Vaccines 145

Drug Topics

OCTOBER 21, 2024

Researchers explored the overall efficacy of various pediatric vaccines and their effects on antibiotic use, while also addressing vaccine hesitancy among parents.

Immunization 502

Immunization Vaccines 502

Hospital Pharmacy Europe

JULY 10, 2024

The UK is switching to a different pertussis vaccine for pregnant women following advice from the Joint Committee on Vaccination and Immunisation. Analysis showed antibody levels to polio type 2 were most affected by the maternal vaccination.

Vaccines 59

Vaccines Immunization Hospitals 59

Hospital Pharmacy Europe

JULY 10, 2024

The UK is switching to a different pertussis vaccine for pregnant women following advice from the Joint Committee on Vaccination and Immunisation. Analysis showed antibody levels to polio type 2 were most affected by the maternal vaccination.

Vaccines 52

Vaccines Immunization Hospitals 52

pharmaphorum

SEPTEMBER 1, 2021

Johnson & Johnson’s HIV vaccine candidate has failed its first major efficacy test, as it was unable to protect women against infection with the virus in a phase 2b trial carried out in sub-Saharan Africa. ” The post J&J vaccine fails to protect women against HIV infection appeared first on.

Vaccines 59

Vaccines Immunization 59

European Pharmaceutical Review

JUNE 27, 2023

difficile infection by the end of 2024 and will be announcing first patient dosed in the Phase II clinical trial of VE202 for ulcerative colitis (UC) shortly too. He has also held the role of Vice President and Therapeutic Area Head, Vaccine Clinical Research at Merck & Co.

Chemotherapy 105

Chemotherapy Immunization FDA Vaccines 105

Drug Topics

OCTOBER 14, 2024

Researchers addressed the prevalence of RSV and its associations with immunization, infection, and hospitalization amongst older adults.

Hospitals 247

Hospitals Immunization Vaccines 247

Drug Topics

JUNE 28, 2024

The updates follow the Advisory Committee for Immunization Practice meeting held June 26 to 28, 2024.

Vaccines 490

Vaccines Immunization 490

The Checkup by Singlecare

OCTOBER 1, 2024

2024 will mark the 20th anniversary of APhM. In addition to the daily workings of the pharmacy, the APhA recommends that the tour include a view of patient care services that warrant compensation, such as immunizations, blood pressure screenings, and comprehensive medication reviews. Why is National Pharmacist Month important?

Patient Care 52

Patient Care Immunization Vaccines 52

European Pharmaceutical Review

MAY 7, 2024

percent compound annual growth rate (CAGR) between 2024 to 2029. Injectable vaccines activate the immune system to help to prevent infectious conditions such as influenza. A new report by MarketsandMarkets has predicted that the injectable drug delivery market will reach an 8.6 The market is anticipated to value $1139.4

Vaccines 94

Vaccines Compounding Immunization FDA 94

Drug Topics

OCTOBER 28, 2024

Before marketing your pharmacy’s immunizations services, check out these takeaways from NCPA.

Immunization 190

Immunization Vaccines 190

Pharmaceutical Technology

JANUARY 6, 2023

If approved, nirsevimab will become the first single-dose preventative against RSV lower respiratory tract disease for the 2023/2024 RSV season in the US. The regulatory body has assigned a Prescription Drug User Fee Act (PDUFA) date for its decision in the third quarter of this year.

FDA 59

FDA Immunization Vaccines 59

PQA

NOVEMBER 1, 2024

We are excited to host members next week at the 2024 PQA Leadership Summit and PQA Convenes: Quality Medication Use in Rare Disease at the Renaissance Arlington Capital View Hotel in Arlington, Va. We also highlight our members' perspectives on health outcomes, oral oncolytics and vaccination recommendations.

Specialty Pharmacies 52

Specialty Pharmacies Vaccines Chemotherapy Immunization 52

Digital Pharmacist

AUGUST 21, 2023

As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. The most effective preventive measure against the flu is getting an annual flu vaccine. According to the CDC, in the 2023-2024 season, the U.S.

Vaccines 98

Vaccines Communication Immunization 98

The Checkup by Singlecare

JULY 12, 2024

They work by binding to the part of the immune system that causes allergic inflammation, said Jason M. In 2024, the FDA also approved Xolair for accidental exposure in people with food allergies. That includes live vaccines such as MMR, varicella, rotavirus, and the intranasal flu vaccine.

Insurance 52

Insurance Insurance Coverage Labelling FDA 52

The Checkup by Singlecare

SEPTEMBER 10, 2024

Stelara biosimilar availability As of July 2024, several biosimilars have been approved by the FDA but are not expected to be available until late February 2025, due to settlements and licensing agreements with Janssen Biotech, the manufacturer of Stelara. Wezlana (ustekinumab-auub) was FDA approved on Oct. Wezlana: Is there a difference?

FDA 52

FDA Vaccines Specialty Pharmacies Pharmaceutical Companies 52

European Pharmaceutical Review

JUNE 28, 2024

The post <em>European Pharmaceutical Review </em> Issue 3 2024 appeared first on European Pharmaceutical Review.

Research Laboratories 52

Research Laboratories Vaccines Immunization 52

PharmaShots

APRIL 25, 2023

Through its internal development, partnerships, and acquisitions, the company has put together four technology platforms that primarily focus on antibodies, T cells, innate immunity, and siRNAs. Currently, AstraZeneca is conducting a P-I clinical trial for the evaluation of ALXN2030 in healthy individuals with data anticipated in 2024.

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Packaging Immunization Vaccines 40

Pharmaceutical Technology

MAY 24, 2023

Morphogenesis’s technologies include Immune Fx (IFx) personalised cancer vaccines and tumour microenvironment (TME) modulators. IFx has been designed to activate an innate immune response against tumour antigens that are patient-specific. Morphogenesis’ lead personalised cancer vaccine, IFx-Hu2.0,

Vaccines 52

Vaccines Immunization 52

Hospital Pharmacy Europe

JULY 11, 2024

Some secondary healthcare staff may be putting themselves at risk of contracting measles and spreading the virus to others by opting out of vaccination, a recent medical journal correspondence has suggested. The researchers stated that all healthcare workers who come in contact with patients should have their immune status assessed.

Immunization 59

Immunization Hospitals Vaccines Patient Care 59

PQA

DECEMBER 15, 2022

Immunization Authority – PQA has prioritized pharmacy performance measure concepts related to immunizations. To support pharmacists’ ability to assess patients’ immunization needs and successfully close gaps in care related to vaccinations, immunization authority should be consistent across states and pharmacy practice sites.

Immunization 40

Immunization Vaccines Specialty Pharmacies Communication 40

Hospital Pharmacy Europe

JULY 11, 2024

Some secondary healthcare staff may be putting themselves at risk of contracting measles and spreading the virus to others by opting out of vaccination, a recent medical journal correspondence has suggested. The researchers stated that all healthcare workers who come in contact with patients should have their immune status assessed.

Immunization 52

Immunization Hospitals Vaccines Patient Care 52

pharmaphorum

JULY 27, 2021

The FDA has approved GlaxoSmithKline’s shingles vaccine Shingrix for use in people aged under 50 who are immunocompromised – a key step in the UK drugmaker’s plan to build the shot into a £4 billion-plus product in the next five years. Shingrix pulled in sales of £2 billion (around $2.8

FDA 52

FDA Vaccines Immunization 52

Drug Topics

JANUARY 8, 2025

These recommendations were voted on at the October 2024 Advisory Committee on Immunization Practices meeting.

Vaccines 190

Vaccines Immunization 190

IDStewardship

MARCH 7, 2025

Although I have practiced in the area of infectious diseases pharmacy for quite a while now, measles has not been of much clinical relevance to me beyond MMR for routine vaccination. Vaccination is the best way to prevent measles This is an obvious one, but necessary to state right out the gate. MMR is given in 2 doses.

Vaccines 299

Vaccines Immunization Communication Hospitals 299

Pharmaceutical Technology

JULY 29, 2022

Pfizer (New York, New York) and Moderna’s (Cambridge, Massachusetts) Omicron-specific Covid-19 vaccines are in late-stage development, have demonstrated good efficacy against the variant and will likely be available to the public later this year to provide an additional booster and increase demand for injectable manufacturing.

Vaccines 52

Vaccines Packaging Immunization FDA 52

Hospital Pharmacy Europe

FEBRUARY 15, 2024

Other potential barriers lie in the risks associated with stimulation of the immune system, which we also need for these agents to work’, Dr Walter continues. However, she adds that ‘approaches using, for example, T-cell stimulating vaccines are currently being explored’.

Chemotherapy 52

Chemotherapy Hospitals Immunization Vaccines 52

PharmaShots

JUNE 1, 2023

PDC*line is much more potent than conventional dendritic cell-based vaccines in priming and boosting antitumor antigen-specific cytotoxic T-cells, including the T-cells specific for neoantigens, and is synergistic with checkpoint inhibitors. We reported at ESMO-IO the analysis of immune response of the first 3 cohorts of patients.

Immunization 40

Immunization Vaccines Health and Personal Care Stores Labelling 40